Supplementary File 3 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, X. Cynthia, Sandeep Rajput et al.|Unknown|2023Cited by 0
Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, X. Cynthia, Sandeep Rajput et al.|Unknown|2023Cited by 0
Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, X. Cynthia, Sandeep Rajput et al.|Unknown|2023Cited by 0
Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, X. Cynthia, Sandeep Rajput et al.|Unknown|2023Cited by 0
Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, X. Cynthia, Shixia Huang et al.|Unknown|2023Cited by 0